Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernesto Ban Hayashi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Archivos De Cardiologia De Mexico|September 12, 2003
[Drug releasing stents]Ernesto Ban Hayashi
Archivos De Cardiologia De Mexico|May 11, 2002
[Septal ablation in the treatment of hypertrophic myocardiopathy]Ernesto Ban Hayashi
Gaceta Medica De Mexico|October 25, 2003
[Trans-septal puncture for radiofrequency ablation of left accessory pathway]Laura L Rodríguez-Chávez, Milton E Guevara-Valdivia, Celso Mendoza-González, et al.
World Journal of Cardiology|February 15, 2014
Primary reperfusion in acute right ventricular infarction: An observational studyEulo Lupi-Herrera, Héctor González-Pacheco, Ursulo Juárez-Herrera, et al.
The New England Journal of Medicine|June 7, 2002
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularizationMarie-Claude Morice, Patrick W Serruys, J Eduardo Sousa, et al.
Circulation|February 23, 2005
Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trialJean Fajadet, Marie-Claude Morice, Christoph Bode, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Archivos De Cardiologia De Mexico|September 12, 2003
[Drug releasing stents]Ernesto Ban Hayashi
Archivos De Cardiologia De Mexico|May 11, 2002
[Septal ablation in the treatment of hypertrophic myocardiopathy]Ernesto Ban Hayashi
Gaceta Medica De Mexico|October 25, 2003
[Trans-septal puncture for radiofrequency ablation of left accessory pathway]Laura L Rodríguez-Chávez, Milton E Guevara-Valdivia, Celso Mendoza-González, et al.
World Journal of Cardiology|February 15, 2014
Primary reperfusion in acute right ventricular infarction: An observational studyEulo Lupi-Herrera, Héctor González-Pacheco, Ursulo Juárez-Herrera, et al.
The New England Journal of Medicine|June 7, 2002
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularizationMarie-Claude Morice, Patrick W Serruys, J Eduardo Sousa, et al.
Circulation|February 23, 2005
Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trialJean Fajadet, Marie-Claude Morice, Christoph Bode, et al.
Pageof 1